0001493152-24-010570.txt : 20240319
0001493152-24-010570.hdr.sgml : 20240319
20240319214806
ACCESSION NUMBER: 0001493152-24-010570
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240317
FILED AS OF DATE: 20240319
DATE AS OF CHANGE: 20240319
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Karkus Ted William
CENTRAL INDEX KEY: 0001457896
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21617
FILM NUMBER: 24766180
MAIL ADDRESS:
STREET 1: 188 HEWLETT NECK ROAD
CITY: WOODMERE
STATE: NY
ZIP: 11598
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ProPhase Labs, Inc.
CENTRAL INDEX KEY: 0000868278
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 232577138
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 711 STEWART AVE, SUITE 200
STREET 2: GARDEN CITY
CITY: NEW YORK
STATE: NY
ZIP: 11530
BUSINESS PHONE: (215) 345-0919
MAIL ADDRESS:
STREET 1: 711 STEWART AVE, SUITE 200
STREET 2: GARDEN CITY
CITY: NEW YORK
STATE: NY
ZIP: 11530
FORMER COMPANY:
FORMER CONFORMED NAME: QUIGLEY CORP
DATE OF NAME CHANGE: 19930328
4
1
ownership.xml
X0508
4
2024-03-17
0
0000868278
ProPhase Labs, Inc.
PRPH
0001457896
Karkus Ted William
711 STEWART AVE,
SUITE 200
GARDEN CITY,
NY
11530
1
1
1
0
CEO & CHAIRMAN
0
Option (right to buy)
6.00
2024-03-17
4
A
0
400000
0.00
D
2031-03-17
Common Stock
400000
400000
D
Options shall vest and become exercisable in four equal installments, with 25% of such award vesting and becoming exercisable on the grant date and the remainder vesting and becoming exercisable in equal annual installments on the first, second and third anniversaries of the grant date.
/s/ Ted Karkus
2024-03-19